Cephalexin Capsule
Product Images NDC 71205-591

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 71205-591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Cephalexin Capsule Powder For Suspension A062702 A 1)

FDA Label Image

71205-591-06 (Cephalexin Capsule Powder For Suspension A062702 A 3)

71205-591-06 (Cephalexin Capsule Powder For Suspension A062702 A 3)
This text describes the packaging details of Cephalexin 500mg capsules, which have been relabeled by Proficient Rx LP. Each capsule contains cephalexin monohydrate USP Gakooo0d” * Eipo0oo and is equivalent to 500mg cephalexin. The product is manufactured by Teva Pharmaceuticals USA, Inc and has a Swedish orange body and cap, with "TEVA" imprinted on the cap and "3147" on the body. The packaging has a Lot #0000 and an expiration date of 00/00/00. The medication should be kept out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.